Seveno Capital Backs PointFit to Disrupt Wearables with Biochemical Patches
Seveno Capital has announced a strategic investment in PointFit, a health-tech startup developing next-generation skin-interfaced wearable patches. The deal signals a significant venture capital shift away from traditional wrist-worn devices toward non-invasive biochemical monitoring.